343 related articles for article (PubMed ID: 27515958)
1. Gut Microbiota and Alcoholic Liver Disease.
Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A
Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958
[TBL] [Abstract][Full Text] [Related]
2. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
3. Alcoholic liver disease: the gut microbiome and liver cross talk.
Hartmann P; Seebauer CT; Schnabl B
Alcohol Clin Exp Res; 2015 May; 39(5):763-75. PubMed ID: 25872593
[TBL] [Abstract][Full Text] [Related]
4. Gut-liver axis in alcoholic liver disease.
Szabo G
Gastroenterology; 2015 Jan; 148(1):30-6. PubMed ID: 25447847
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
6. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
7. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
8. Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases.
Park JW; Kim SE; Lee NY; Kim JH; Jung JH; Jang MK; Park SH; Lee MS; Kim DJ; Kim HS; Suk KT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008852
[TBL] [Abstract][Full Text] [Related]
9. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin A and liver diseases.
Inamine T; Schnabl B
J Gastroenterol; 2018 Jun; 53(6):691-700. PubMed ID: 29075899
[TBL] [Abstract][Full Text] [Related]
11. Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis.
Scarpellini E; Lupo M; Iegri C; Gasbarrini A; De Santis A; Tack J
Rev Recent Clin Trials; 2014; 9(3):141-7. PubMed ID: 25514911
[TBL] [Abstract][Full Text] [Related]
12. Bifidobacterium longum subsp. longum BL21 ameliorates alcoholic liver disease in mice through enhancement of the hepatic antioxidant capacity and modulation of the gut microbiota.
Dong Y; Wu Z; Gai Z; Han M
J Appl Microbiol; 2023 Nov; 134(11):. PubMed ID: 37930723
[TBL] [Abstract][Full Text] [Related]
13. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
[TBL] [Abstract][Full Text] [Related]
14. The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.
Huang W; Kong D
Biomed Pharmacother; 2021 Mar; 135():111235. PubMed ID: 33561650
[TBL] [Abstract][Full Text] [Related]
15. Alcoholic liver disease: focus on prodromal gut health.
Park B; Lee HR; Lee YJ
J Dig Dis; 2016 Aug; 17(8):493-500. PubMed ID: 27356233
[TBL] [Abstract][Full Text] [Related]
16. Recovery of ethanol-induced
Grander C; Adolph TE; Wieser V; Lowe P; Wrzosek L; Gyongyosi B; Ward DV; Grabherr F; Gerner RR; Pfister A; Enrich B; Ciocan D; Macheiner S; Mayr L; Drach M; Moser P; Moschen AR; Perlemuter G; Szabo G; Cassard AM; Tilg H
Gut; 2018 May; 67(5):891-901. PubMed ID: 28550049
[TBL] [Abstract][Full Text] [Related]
17. NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease.
Mainz RE; Albers S; Haque M; Sonntag R; Treichel NS; Clavel T; Latz E; Schneider KM; Trautwein C; Otto T
Cells; 2022 Jan; 11(2):. PubMed ID: 35053298
[TBL] [Abstract][Full Text] [Related]
18. Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-Mψ Axis and Modulating Gut Microbiota in Mice.
Yang X; He F; Zhang Y; Xue J; Li K; Zhang X; Zhu L; Wang Z; Wang H; Yang S
Alcohol Clin Exp Res; 2019 Mar; 43(3):411-424. PubMed ID: 30589437
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Complications of Liver Disease.
Acharya C; Bajaj JS
Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
[TBL] [Abstract][Full Text] [Related]
20. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]